These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Qi L; Wu L; Zheng S; Wang Y; Fu H; Cui D Biomacromolecules; 2012 Sep; 13(9):2723-30. PubMed ID: 22913876 [TBL] [Abstract][Full Text] [Related]
8. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics. Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023 [TBL] [Abstract][Full Text] [Related]
9. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach. Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280 [TBL] [Abstract][Full Text] [Related]
10. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells. Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922 [TBL] [Abstract][Full Text] [Related]
12. Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles. Kong WH; Bae KH; Jo SD; Kim JS; Park TG Pharm Res; 2012 Feb; 29(2):362-74. PubMed ID: 21842305 [TBL] [Abstract][Full Text] [Related]
13. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy. Mainini F; Eccles MR Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030 [TBL] [Abstract][Full Text] [Related]
14. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery. He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844 [TBL] [Abstract][Full Text] [Related]
15. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]
16. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry. Kapilov-Buchman Y; Lellouche E; Michaeli S; Lellouche JP Bioconjug Chem; 2015 May; 26(5):880-9. PubMed ID: 25830668 [TBL] [Abstract][Full Text] [Related]
17. Recent patents in siRNA delivery employing nanoparticles as delivery vectors. Nimesh S Recent Pat DNA Gene Seq; 2012 Aug; 6(2):91-7. PubMed ID: 22670609 [TBL] [Abstract][Full Text] [Related]
18. Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer. Tzeng SY; Green JJ Adv Healthc Mater; 2013 Mar; 2(3):468-80. PubMed ID: 23184674 [TBL] [Abstract][Full Text] [Related]
19. Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA. Morsi NG; Ali SM; Elsonbaty SS; Afifi AA; Hamad MA; Gao H; Elsabahy M Pharm Dev Technol; 2018 Apr; 23(4):387-399. PubMed ID: 28347210 [TBL] [Abstract][Full Text] [Related]